Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 88 filers reported holding Y-MABS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $126,714 | -68.9% | 25,966 | -8.1% | 0.00% | -50.0% |
| Q3 2022 | $407,000 | +60.9% | 28,251 | +81.4% | 0.00% | 0.0% |
| Q4 2021 | $253,000 | -19.7% | 15,577 | +49.3% | 0.00% | -60.0% |
| Q1 2021 | $315,000 | -44.3% | 10,433 | -20.4% | 0.01% | -37.5% |
| Q2 2020 | $566,000 | +138.8% | 13,111 | +72.8% | 0.01% | +14.3% |
| Q4 2019 | $237,000 | – | 7,588 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sofinnova Investments, Inc. | 2,104,278 | $55,890,000 | 4.98% |
| SCOPIA CAPITAL MANAGEMENT LP | 1,587,566 | $42,166,000 | 0.81% |
| DC Investments Management, LLC | 25,000 | $664,000 | 0.45% |
| Monashee Investment Management LLC | 67,800 | $1,801,000 | 0.38% |
| Avoro Capital Advisors LLC | 310,000 | $8,234,000 | 0.38% |
| Cormorant Asset Management, LP | 200,000 | $5,312,000 | 0.34% |
| PURA VIDA INVESTMENTS, LLC | 22,350 | $594,000 | 0.12% |
| Artal Group S.A. | 150,000 | $3,984,000 | 0.10% |
| OXFORD ASSET MANAGEMENT LLP | 59,122 | $1,556,000 | 0.03% |
| Point72 Hong Kong Ltd | 3,252 | $86,000 | 0.03% |